Chargement en cours...
Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
We aimed to investigate the clinical factors affecting the therapeutic effectiveness of the sodium–glucose cotransporter-2 inhibitor empagliflozin in patients with type 2 diabetes mellitus (T2DM). We reviewed the medical records of 374 T2DM patients aged between 20 and 75 years who were prescribed e...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6675078/ https://ncbi.nlm.nih.gov/pubmed/31369642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0220667 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|